Changes in the Body Composition and Nutritional Status after Long-term Rifaximin Therapy for Hyperammonemia in Japanese Patients with Hepatic Encephalopathy-Reference-Cited by-同舟云学术

Changes in the Body Composition and Nutritional Status after Long-term Rifaximin Therapy for Hyperammonemia in Japanese Patients with Hepatic Encephalopathy

Published:2020-10-15 Issue:20 Volume:59 Page:2465-2469
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Ishikawa Toru¹,Endo Saori¹,Imai Michitaka¹,Azumi Motoi¹,Nozawa Yujiro¹,Sano Tomoe¹,Iwanaga Akito¹,Honma Terasu¹,Yoshida Toshiaki¹

Affiliation:

1. Department of Gastroenterology and Hepatology, Saiseikai Niigata Hospital, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/59/20/59_5094-20/_pdf

Reference23 articles.

1. 1. Vilstrup H, Amodio P, Bajaj J, et al. Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver. Hepatology 60: 715-735, 2014.

2. 2. Wijdicks EF. Hepatic encephalopathy. N Engl J Med 375: 1660-1670, 2016.

3. 3. Iwasa M, Takei Y. Pathophysiology and management of hepatic encephalopathy 2014 update: ammonia toxicity and hyponatremia. Hepatol Res 45: 1155-1162, 2015.

4. 4. Bass NM, Mullen KD, Sanyal A, et al. Rifaximin treatment in hepatic encephalopathy. N Engl J Med 362: 1071-1081, 2010.

5. 5. Jiang Q, Jiang XH, Zheng MH, et al. Rifaximin versus nonabsorbable disaccharides in the management of hepatic encephalopathy: a meta-analysis. Eur J Gastroenterol Hepatol 20: 1064-1070, 2008.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Frailty in end-stage liver disease: Understanding pathophysiology, tools for assessment, and strategies for management;World Journal of Gastroenterology;2023-12-14

2. Sarcopenia in cirrhosis: Prospects for therapy targeted to gut microbiota;World Journal of Gastroenterology;2023-07-21

3. The ALBI score: From liver function in patients with HCC to a general measure of liver function;JHEP Reports;2022-10

4. Long-Term Effects of Rifaximin on Patients with Hepatic Encephalopathy: Its Possible Effects on the Improvement in the Blood Ammonia Concentration Levels, Hepatic Spare Ability and Refractory Ascites;Medicina;2022-09-14

5. Long-Term Efficacy and Safety of Rifaximin in Japanese Patients with Hepatic Encephalopathy: A Multicenter Retrospective Study;Journal of Clinical Medicine;2022-03-12